Invicta Diagnostic P/B Ratio
Current P/B Ratio
1.68
Moderate Valuation
Moderate - Reasonably valued relative to book value
Invicta Diagnostic P/B ratio. Invicta Diagnostic (INVICTA) P/B ratio is 1.68 (Moderate), book value per share ₹38.46 vs Healthcare Services average P/B of -12.37 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see INVICTA screener.
Current Valuation Metrics
P/B Ratio
1.68
Current Price
₹
Book Value/Share
₹38.46
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹50 Cr
Share Capital
₹13 Cr
Reserves & Surplus
₹37 Cr
Outstanding Shares
13,000,000
Book Value per Share
₹38.46
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-12.37
Sector Median
1.89
Sector Rank
#11 of 50
Sector Percentile
22.0%
INVICTA P/B Ratio — Valuation Insights & Book Value Analysis
Invicta Diagnostic price-to-book ratio interpretation, valuation status and historical context — current P/B 1.68 (Moderate). View INVICTA 52-week high low for the annual high/low range and current price position.
- Trading at premium to sector average PB of -12.37
INVICTA vs Healthcare Services Peers — P/B Ratio Comparison
Invicta Diagnostic P/B 1.68 vs Healthcare Services average -12.37, median 1.89 — range -747.86–7.23.
Sector Average
-12.37
Sector Median
1.89
Lowest P/B
-747.86
Highest P/B
7.23
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Medinova Diagnostic Serv… | MEDINOV | -747.86 | ₹44 | Low |
| Chennai Meenakshi Multis… | CMMHOSP | -8.89 | ₹27 | Low |
| Nidan Labs & Healthcare | NIDAN | 0.26 | ₹17 | Low |
| Gian Life Care | GIANLIFE | 0.26 | ₹5 | Low |
| Deccan Health Care | DECCAN | 0.27 | ₹29 | Low |
| Dr Lalchandani Labs | DLCL | 0.42 | ₹6 | Low |
| Global Longlife Hospital… | GLHRL | 0.54 | ₹12 | Low |
| Ashram Online.Com | ASHRAM | 0.58 | ₹7 | Low |
| Looks Health Services | LOOKS | 0.68 | ₹10 | Low |
| BOSTON BIO SYSTEMS LTD. | BOSTONBIO | 0.7 | ₹4 | Low |